AbbVie Inc Capital Reinvestment Ratio
AbbVie Inc capital reinvestment ratio. AbbVie Inc (ABBV) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow ($5.22 Billion) in capital expenditures ($329.00 Million). Check AbbVie Inc (ABBV) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AbbVie Inc (2009–2025)
Capital reinvestment ratio of AbbVie Inc from 2009 to 2025. This chart tracks AbbVie Inc's Capital Reinvestment Ratio across 17 annual periods. Also explore ABBV year-over-year net asset growth to track the company's year-over-year net asset growth rate.
AbbVie Inc Capital Reinvestment Ratio by Year (2009–2025)
AbbVie Inc capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see AbbVie Inc (ABBV) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $19.03 Billion | $1.21 Billion | ▲ +23.2% |
| 2024 | 0.05x | $18.81 Billion | $974.00 Million | ▲ +52.2% |
| 2023 | 0.03x | $22.84 Billion | $777.00 Million | ▲ +22.1% |
| 2022 | 0.03x | $24.94 Billion | $695.00 Million | ▼ -19.4% |
| 2021 | 0.03x | $22.78 Billion | $787.00 Million | ▼ -23.8% |
| 2020 | 0.05x | $17.59 Billion | $798.00 Million | ▲ +9.5% |
| 2019 | 0.04x | $13.32 Billion | $552.00 Million | ▼ -12.8% |
| 2018 | 0.05x | $13.43 Billion | $638.00 Million | ▼ -10.5% |
| 2017 | 0.05x | $9.96 Billion | $529.00 Million | ▼ -21.9% |
| 2016 | 0.07x | $7.04 Billion | $479.00 Million | ▼ -3.6% |
| 2015 | 0.07x | $7.54 Billion | $532.00 Million | ▼ -59.1% |
| 2014 | 0.17x | $3.55 Billion | $612.00 Million | ▲ +120.1% |
| 2013 | 0.08x | $6.27 Billion | $491.00 Million | ▲ +49.3% |
| 2012 | 0.05x | $6.34 Billion | $333.00 Million | ▼ -7.8% |
| 2011 | 0.06x | $6.25 Billion | $355.51 Million | ▼ -36.8% |
| 2010 | 0.09x | $4.98 Billion | $448.00 Million | ▲ +54.6% |
| 2009 | 0.06x | $5.37 Billion | $312.56 Million | — |